India is following a human-centric approach to furthering global good, which is based on healthy balanced welfare and well-being, he said, virtually delivering the valedictory address to 'Heartfulness Practitioners' on the platinum jubilee celebrations of Heartfulness Institute of Shri Ram Chandra Mission.
The daily new COVID-19 cases fell below 10,000 for the third time this month taking India's tally of cases to 1,08,80,603, while fresh fatalities were recorded below 100 for the seventh time in February, according to the Union Health Ministry data updated on Friday.
India's cumulative COVID-19 positivity rate has declined to 5.42 per cent while the weekly positivity rate (last week) was recorded at 1.82 per cent, the Union Health Ministry said on Thursday.
With 13,052 new coronavirus infections being reported in a day, India's COVID-19 tally has gone up to 1,07,46,183, while the number of people who have recuperated from the disease has surged to 1,04,23,125, according to the Union Health Ministry data updated on Sunday.
India reported 18,855 new COVID-19 cases in the last 24 hours, taking the country's coronavirus tally to 1,07,20,048, as per the Union Health Ministry bulletin.
As many as 16,946 new COVID-19 cases were recorded in the last 24 hours, taking the total number of confirmed coronavirus cases to 1,05,12,093, as per Union Health Ministry's latest bulletin released on Thursday.
In a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.
Taking to Twitter, Congress MP Shashi Tharoor said, "The Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous."
Senior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for the restricted use of Bharat Biotech's COVID-19 vaccine and asked the government to explain why mandatory protocols and verification of data has been dispensed with. India's drugs regulator DCGI on Sunday approved Oxford's COVID-19 vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use.
In a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.
The panel has recommended to the government that any vaccine against COVID-19 should be granted emergency use authorisation only after proper consideration and conducting its trials on a sufficient sample size.
The expert panel has recommended granting permission for restricted emergency use of 'Covaxin' in "public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains.
A total of 1,47,901 deaths have been reported so far in the country including 49,255 from Maharashtra followed by 12,062 from Karnataka, 12,069 from Tamil Nadu, 10,453 from Delhi, 9,598 from West Bengal, 8,306 from Uttar Pradesh, 7,094 from Andhra Pradesh and 5,299 from Punjab.
The coronavirus crisis is now 'on its way out' and 'soon' vaccines would be available in India too, Union Information and Broadcasting Minister Prakash Javadekar said on Monday. He was speaking at the International Coronavirus Short Film Festival.
India's coronavirus active caseload has dipped to 4.03 lakh, the lowest after 138 days, comprising 4.18 per cent of the total COVID-19 infections reported so far in the country, Union Health Ministry said on Sunday.
India's coronavirus active cases have remained below the 5-lakh mark, with its share further shrinking to 4.60 per cent of the total COVID-19 infections reported so far, Union Health Ministry on Tuesday informed.
According to the ICMR, over 13.17 crore samples have been tested up to November 22 with 10,75,326 samples being tested on Saturday.
From the development of indigenous vaccines to novel point-of-care diagnostics, India has initiated an integrated response to overcome the unprecedented COVID-19 pandemic, Union minister Harsh Vardhan said on Saturday.
India has conducted the second-highest number of tests for detection of COVID-19 in the world at 11.96 crore with rapid antigen tests comprising 49 per cent and RT-PCR 46 per cent of the total tests done till Tuesday morning, the Union Health Ministry said.
India's COVID-19 case fatality rate (CFR) fell below 1.5 per cent on Saturday, the Union health ministry said, crediting the Centre-led strategy of 'test, trace, track and treat' for keeping coronavirus-related deaths low and within manageable numbers.
Top News
Latest News
